“SAHaRA: A Randomized Controlled Trial”
The SAHaRA trial will clarify the role of treating anemia with Red Blood Cell (RBC) transfusion in a unique and vulnerable patient population, and determine whether that impacts on functional outcomes and mortality. It will guide best practice standards and clarify the optimal RBC transfusion strategy in patients with aSAH.
Liberal RBC Transfusion Strategy
RBC transfusion is triggered by a Hemoglobin value of â‰¤100g/L
Restrictive RBC Transfusion Strategy
Optional RBC transfusion is triggered by a Hemoglobin value of â‰¤80g/L
Aneurysmal Subarachnoid Hemorrhage - Red Blood Cell Transfusion and Outcome (SAHaRA): A Randomized Controlled Trial